Genovate Biotechnology Co., Ltd. (GBL), a fully integrated biopharmaceutical company located in Taiwan, pursues the following missions: 1) Establish and meet the US FDA's standards for current Good Manufacturing Practice (cGMP) and manufacture high quality products; 2) Bring together leading-edge technologies and talented people domestically and from overseas for the research and development of new therapeutic agents; 3) Conduct clinical studies in accordance with International Conference on Harmonisation (ICH) Guideline for Good Clinical Practice (GCP).